Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nautilus Biotechnology Inc (NAUT)

  7. Nautilus Biotechnology Inc (NAUT) News

NAUT

Nautilus Biotechnology Inc
2.51
0.00 (0.0%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Nautilus Biotechnology Inc NAUT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 2.51 17:57:54
Open Price Low Price High Price Close Price Prev Close
2.50 2.49 2.55 2.51 2.51
more quote information »

Recent News

Date Time Source Heading
3/23/202308:00GLOBENautilus Biotechnology to Participate in B. Riley..
3/07/202308:00GLOBENautilus Biotechnology Announces “First Access Challenge”..
3/01/202317:20EDGARStatement of Changes in Beneficial Ownership (4)
3/01/202317:20EDGARStatement of Changes in Beneficial Ownership (4)
3/01/202317:19EDGARStatement of Changes in Beneficial Ownership (4)
3/01/202317:19EDGARStatement of Changes in Beneficial Ownership (4)
3/01/202317:19EDGARStatement of Changes in Beneficial Ownership (4)
3/01/202317:18EDGARStatement of Changes in Beneficial Ownership (4)
3/01/202315:31EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
2/23/202316:22EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/23/202316:13EDGARAnnual Report (10-k)
2/23/202306:05GLOBENautilus Biotechnology Reports Fourth Quarter and Fiscal..
2/23/202306:01EDGARCurrent Report Filing (8-k)
2/21/202308:00GLOBENautilus Biotechnology to Participate in the 43rd Annual..
2/13/202316:16EDGARStatement of Ownership (sc 13g)
1/26/202308:00GLOBENautilus Biotechnology to Announce Fourth Quarter and Full..
1/26/202307:45GLOBENautilus Biotechnology Expands to San Diego
1/19/202308:00GLOBENautilus Biotechnology Partners with the Translational..
11/16/202208:00GLOBENautilus Biotechnology Launches “First Access Challenge”
11/01/202216:10EDGARQuarterly Report (10-q)
11/01/202206:10EDGARAmended Current Report Filing (8-k/a)
11/01/202206:08EDGARCurrent Report Filing (8-k)
11/01/202206:05GLOBENautilus Biotechnology Reports Third Quarter 2022 Financial..
10/05/202208:00GLOBENautilus Biotechnology to Announce Third Quarter 2022..
9/23/202208:00GLOBENautilus Biotechnology to Participate in the Capital One..
9/19/202217:51EDGARStatement of Changes in Beneficial Ownership (4)
9/01/202208:00GLOBENautilus Biotechnology Joins Human Proteome Organization..
8/30/202208:00GLOBENautilus Biotechnology to Participate in the Morgan Stanley..
8/22/202219:41EDGARStatement of Changes in Beneficial Ownership (4)
8/09/202216:23EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/09/202206:08EDGARNotice of Effectiveness (effect)
8/08/202219:49EDGARStatement of Changes in Beneficial Ownership (4)
8/03/202212:45TRMNNautilus Biotechnolgy (NAUT) Gets a Hold Rating from Goldman..
8/03/202212:44TRMNNautilus Biotechnolgy (NAUT) Gets a Hold Rating from Morgan..
8/02/202216:28EDGARPost-effective Amendment to Registration Statement (pos Am)
8/02/202216:25EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/02/202216:05EDGARQuarterly Report (10-q)
8/02/202206:48GLOBENautilus Biotechnology Reports Second Quarter 2022 Financial..
8/02/202206:00EDGARCurrent Report Filing (8-k)
8/01/202216:05GLOBENautilus Biotechnology Appoints Eric Spence as Vice..
7/14/202212:49TRMNGoldman Sachs Reaffirms Their Hold Rating on Nautilus..
7/13/202208:00GLOBENautilus Biotechnology to Announce Second Quarter 2022..
7/01/202217:31EDGARInitial Statement of Beneficial Ownership (3)
6/28/202218:18EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:44EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202216:07EDGARCurrent Report Filing (8-k)
5/17/202205:03TRMNNautilus Biotechnolgy (NAUT) Receives a Buy from Jefferies
5/13/202217:10EDGARStatement of Changes in Beneficial Ownership (4)
5/05/202217:20EDGARStatement of Changes in Beneficial Ownership (4)
5/05/202217:16EDGARStatement of Changes in Beneficial Ownership (4)